Clinical trial
Bi-directional Real-world Cohort Study on Sotrovimab and Its Impact on the Strength and Duration of the Immune Response to Natural SARS-CoV-2 Infection in Real-life Setting in the UAE and the Kingdom of Bahrain
NCT05398718 is registered in ClinicalTrials.gov with Abu Dhabi Health Services Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bi-directional Real-world Cohort Study on Sotrovimab and Its Impact on the Strength and Duration of the Immune Response to Natural SARS-CoV-2 Infection in Real-life Setting in the UAE and the Kingdom of Bahrain
- Lead sponsor
- Abu Dhabi Health Services Company
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 12, 2022
- Completion date
- December 31, 2022
- Enrollment
- 20,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.